Page last updated: 2024-09-03

cimadronate and Bone Neoplasms

cimadronate has been researched along with Bone Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's6 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asahi, H; Komatsu, K; Koshida, K; Maeda, Y; Mizokami, A; Namiki, M1
Futakuchi, M; Hikosaka, A; Kohri, K; Ogiso, T; Shirai, T; Suzuki, S1
Kubo, T; Matsuo, T; Ochi, M; Sakai, A; Shimose, S; Tanaka, K; Yasunaga, Y1
Fujii, Y; Fukui, I; Kijima, T; Okubo, Y; Suyama, T; Yonese, J1
Koizumi, M; Ogata, E1
Hiraga, T; Nakajima, T; Ozawa, H; Tanaka, S; Yamamoto, M1
Higuchi, S; Nakamura, E; Ozawa, Y; Sonoda, T; Tanaka, S; Teramura, K; Usui, T; Watanabe, T1
Kokawa, Y; Naito, Y; Oura, S; Sakurai, T; Tamaki, T; Umemura, T; Yoshimura, G1
Fukuda, K; Kim, YH; Kitano, H; Kokufu, I; Taniguchi, H; Yamada, K; Yamamoto, M; Yano, T1
Iwao, H; Ochi, H; Shigematsu, M; Shomi, S1

Other Studies

10 other study(ies) available for cimadronate and Bone Neoplasms

ArticleYear
Bisphosphonate therapy for hormone refractory prostate cancer with bone metastasis.
    The Journal of urology, 2003, Volume: 169, Issue:1

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Diphosphonates; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estramustine; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms

2003
Lack of prophylactic effect of incadronate on skeletal lesions associated with implants of prostate cancer.
    European urology, 2006, Volume: 49, Issue:1

    Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Male; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rats, Inbred F344; Treatment Failure

2006
Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2006, Volume: 24, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imidazoles; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Sarcoma; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2006
Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.
    International journal of urology : official journal of the Japanese Urological Association, 2008, Volume: 15, Issue:6

    Topics: Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Imidazoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Pamidronate; Zoledronic Acid

2008
Bisphosphonate effect on bone scintigraphy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2

    Topics: Bone and Bones; Bone Neoplasms; Diphosphonates; Humans; Radionuclide Imaging

1996
Inhibitory effects of bisphosphonate (YM175) on bone resorption induced by a metastatic bone tumor.
    Bone, 1996, Volume: 18, Issue:1

    Topics: Acid Phosphatase; Animals; Biomarkers, Tumor; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Immunohistochemistry; Isoenzymes; Male; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Tartrate-Resistant Acid Phosphatase; Tumor Cells, Cultured

1996
Drug disposition of incadronate, a new bisphosphonate, in rats with bone metastases.
    Xenobiotica; the fate of foreign compounds in biological systems, 1997, Volume: 27, Issue:5

    Topics: Animals; Autoradiography; Bone Neoplasms; Cell Division; Diphosphonates; Half-Life; Male; Melanoma, Experimental; Metabolic Clearance Rate; Neoplasm Transplantation; Rats; Rats, Nude

1997
[Study on the safety of rapid infusion and the efficacy of incadronate against bone metastasis of breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:11

    Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Middle Aged

1999
[A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2000, Volume: 27, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Floxuridine; Humans; Medroxyprogesterone Acetate; Middle Aged; Pamidronate

2000
New bone-seeking agent: animal study of Tc-99m-incadronate.
    Annals of nuclear medicine, 2002, Volume: 16, Issue:1

    Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Feasibility Studies; Female; Hydrogen-Ion Concentration; Kidney; Models, Molecular; Muscles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Sodium Pertechnetate Tc 99m; Tissue Distribution; Urine; Whole-Body Counting

2002